BlackRock Investment Management’s Meridian Bioscience Inc VIVO Stock Holding History

BlackRock Investment Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$3.86M	Buy	217,950 +39,681	+22%	+$697K	﹤0.01%	1766
2016 Q3	$3.44M	Buy	178,269 +248	+0.1%	+$4.85K	﹤0.01%	1746
2016 Q2	$3.47M	Buy	178,021 +14,548	+9%	+$285K	﹤0.01%	1697
2016 Q1	$3.37M	Buy	163,473 +1,618	+1%	+$31.9K	﹤0.01%	1641
2015 Q4	$3.32M	Buy	161,855 +1,385	+0.9%	+$26.6K	﹤0.01%	1695
2015 Q3	$2.74M	Sell	160,470 -1,317	-0.8%	-$24.1K	﹤0.01%	1825
2015 Q2	$3.02M	Buy	161,787 +23,767	+17%	+$441K	﹤0.01%	1899
2015 Q1	$2.63M	Buy	138,020 +2,137	+2%	+$39.5K	﹤0.01%	1832
2014 Q4	$2.24M	Sell	135,883 -653	-0.5%	-$11.2K	﹤0.01%	1953
2014 Q3	$2.42M	Sell	136,536 -110	-0.1%	-$2.16K	﹤0.01%	1864
2014 Q2	$2.82M	Sell	136,646 -931	-0.7%	-$19.1K	﹤0.01%	1807
2014 Q1	$3M	Buy	137,577 +823	+0.6%	+$18.9K	﹤0.01%	1760
2013 Q4	$3.63M	Sell	136,754 -1,812	-1%	-$44.5K	0.01%	1576
2013 Q3	$3.27M	Buy	138,566 +6,601	+5%	+$154K	0.01%	1589
2013 Q2	$2.84M	Buy	+131,965	New	+$2.85M	0.01%	1601

Other funds holding VIVO

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

BlackRock Investment Management's VIVO Position: Q4 2016 in Review

BlackRock Investment Management increased its Meridian Bioscience Inc (VIVO) stake by 22% in Q4 2016, buying an estimated $697K and bringing the position to 217,950 shares worth $3.86M. The position accounts for ﹤0.01% of the portfolio, ranked #1766.

BlackRock Investment Management first reported a position in VIVO in Q2 2013 and has held it in 15 quarters since. 180 funds tracked by Wall St. Rank hold VIVO as of Q4 2016.

BlackRock Investment Management held 217,950 shares of Meridian Bioscience Inc worth $3.86M as of Q4 2016.
BlackRock Investment Management bought 39,681 Meridian Bioscience Inc shares in Q4 2016, an estimated $697K.
Meridian Bioscience Inc made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #1766 holding.
BlackRock Investment Management first reported a position in Meridian Bioscience Inc in Q2 2013 and has held it in 15 quarters since.
180 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.